MOL-4239

N/A

Report date: 2025/11/15 20:00:09
NME

Base Information

Drug NameMOL-4239
Drug Alias NameMOL-4239WP-1220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsPsoriasisMycosis FungoidesLymphoma, T-Cell, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPoland
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMoleculin Biotech IncMoleculin Llc
Active IndicationsN/A
Inactive IndicationsPsoriasisMycosis FungoidesLymphoma, T-Cell, Cutaneous

Other Information

ATC CodeN/A
Related LinksDrugBank